Acta Medica
Rituximab Therapy in Chronic Childhood Immune Thrombocytopenic Purpura: Is it worth trying?
Yazarlar: GoncaKEKİNEİRCİ, ügeGÖKÇE, enizTUĞCU, CengizAYRA, evinçGENÇ, GönülAYOĞAN
Cilt 46 , Sayı 1 , 2015 , Sayfalar -
Konular:-
Anahtar Kelimeler:-
Özet: -
ATIFLAR
Atıf Yapan Eserler
KAYNAK GÖSTER
BibTex
@article{2015, title={Rituximab Therapy in Chronic Childhood Immune Thrombocytopenic Purpura: Is it worth trying?}, volume={46}, publisher={Acta Medica}, author={Gonca KESKİNDEMİRCİ, [MD]; Müge GÖKÇE, [MD] [PhD] (Author); Deniz TUĞCU, [MD] [PhD], Cengiz BAYRAM, [MD], Sevinç GENÇ, [MD], Gönül AYDOĞAN, [MD]}, year={2015} }
APA
Gonca KESKİNDEMİRCİ, [MD]; Müge GÖKÇE, [MD] [PhD] (Author); Deniz TUĞCU, [MD] [PhD], Cengiz BAYRAM, [MD], Sevinç GENÇ, [MD], Gönül AYDOĞAN, [MD]. (2015). Rituximab Therapy in Chronic Childhood Immune Thrombocytopenic Purpura: Is it worth trying? (Vol. 46). Vol. 46. Acta Medica.
MLA
Gonca KESKİNDEMİRCİ, [MD]; Müge GÖKÇE, [MD] [PhD] (Author); Deniz TUĞCU, [MD] [PhD], Cengiz BAYRAM, [MD], Sevinç GENÇ, [MD], Gönül AYDOĞAN, [MD]. Rituximab Therapy in Chronic Childhood Immune Thrombocytopenic Purpura: Is It Worth Trying? no., Acta Medica, 2015.